Cost Versus Benefits

Cost Versus Benefits Author: Philip Perotti, p.12 I'd like to comment on the article entitled "Chemists Anxious About Discipline's Fate" in your publication dated April 1, 1991 [page 1]. As a somewhat recent university graduate (1986) with degrees in both microbiology and biochemistry, I think I have a fresh perspective on why the sciences in general, and chemistry in particular, are failing to attract young minds. We all know that the study of science is not an easy endeavor. As comparative c

Written byPhilip Perotti
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Cost Versus Benefits

Author: Philip Perotti, p.12

I'd like to comment on the article entitled "Chemists Anxious About Discipline's Fate" in your publication dated April 1, 1991 [page 1].

As a somewhat recent university graduate (1986) with degrees in both microbiology and biochemistry, I think I have a fresh perspective on why the sciences in general, and chemistry in particular, are failing to attract young minds.

We all know that the study of science is not an easy endeavor. As comparative curricula go, I think science (especially chemistry) is one of the hardest disciplines to tackle. The amount of hands-on lab time spent by undergraduates to learn their craft is quite overwhelming to freshmen. I am not in any way saying that the class load or material should be scaled down. On the contrary, I think in some cases more coursework is needed. My point is that human nature drives ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies